Results 281 to 290 of about 4,484,991 (333)

Adherence to Aromatase Inhibitor Therapy in Breast Cancer: Insights From a Multicenter Italian Study. [PDF]

Breast J
Fabbri MA, Fulvi A, Vergati M, D'Auria G, Vici P, Filomeno L, Arcuri T, Palazzo A, Nelli F, Fiore C, Portarena I, Falbo PT, Rossi R, Alesini D, Sini V, Pace R, Frittelli P, Corsi DC, Palombi L, Pisegna S, Botticelli A, Scagnoli S, Pistillucci G, Giordani E, La Cesa A.   +24 more
europepmc   +1 more source

Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets. [PDF]

Cureus
Ohashi R, Yasunaga S, Ishimura A, Furuya T, Aizawa Y, Omori T, Kurita T, Nakajima T, Takizawa Y.   +8 more
europepmc   +1 more source

Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML. [PDF]

Front Oncol
Schroer AE, Javadi T, Mehta A, Torlak F, McFarland JR, Kumar G, da Silva AL, Benjamin J, Choudhary MM, Sadeghi A, le Coutre P, Blaha MJ, Berning P, Dzaye O.   +13 more
europepmc   +1 more source

Estimating Costs of Market Exclusivity Extensions For 4 Top-Selling Prescription Drugs in the US.

JAMA Health Forum
Hong D, Tu SS, Beall RF, Russo M, Rome BN, Kesselheim AS, Sarpatwari A.   +6 more
europepmc   +1 more source

Assessment of Prescription Writing Pattern in a Tertiary Care Center and Hospital at Vidisha Madhya Pradesh: A Prospective Study.

J Pharm Bioallied Sci
Jain SK, Chouksey VK, Singh B, Maurya PK.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012–2018

Clinical pharmacology and therapy, 2020
Brand‐name drugs have periods of market exclusivity before generic competition begins. Due to high brand‐name drug prices charged during this period, market exclusivity is an important determinant of US prescription drug spending.
Benjamin N. Rome, ChangWon C. Lee, A. Kesselheim   +2 more
semanticscholar   +1 more source

Generic antiepileptic drugs

Current Treatment Options in Neurology, 2008
Generic antiepileptic drugs (AEDs) generally provide safe, effective, lower-cost alternatives to brand-name drugs. To be approved by the US Food and Drug Administration (FDA), manufacturers must show that generic drugs are comparable to brand-name formulations, meeting bioequivalence, dissolution, and manufacturing quality standards. Bioequivalence for
Susan J, Shaw, Gregory L, Krauss
openaire   +2 more sources

Innovation for Generic Drugs: Science and Research Under the Generic Drug User Fee Amendments of 2012

Clinical pharmacology and therapy, 2019
Regulatory science is science and research intended to improve decision making in a regulatory framework. Improvements in decision making can be in both accuracy (making better decisions) and in efficiency (making faster decisions).
R. Lionberger
semanticscholar   +1 more source